Nav: Home

New sepsis treatment a step closer

December 11, 2018

Australian emergency doctors are at the forefront of a large clinical study to assess how clinicians are treating sepsis.

Funded by the Emergency Medicine Foundation -- Australasia (EMF) and the Gold Coast Hospital Foundation, the study will help clinicians better understand how patients in Australia and New Zealand are currently managed and could lead to a potential new way of treating the life-threatening illness.

Study co-leader, Gold Coast Health Emergency Specialist Professor Gerben Keizjers said he was hopeful the study would lead to a major treatment change for sepsis, which affects an estimated 18,000 Australians each year, causes more than 5000 deaths and costs the national healthcare system more than $700 million each year.

"When a patient with sepsis arrives at the emergency department, the standard treatment is to give them a relatively large dose of intravenous fluids, which is often two to three litres or more for an adult," said Professor Keijzers.

"Sepsis causes the blood pressure to drop, so the thinking has been that if we give the patient fluids it will increase their blood pressure and ensure oxygen reaches important organs such as the brain and kidneys.

"This has been the accepted practice for more than 60 years, but recent research results have led us to question the benefits of giving large amounts of intravenous fluids to septic patients.

"Unfortunately, it's now unclear what the best course of treatment is."

To help answer this question, the researchers are running the 'ARISE Fluids' study (Fluid resuscitation in emergency patients with sepsis and hypotension), which will involve more than 70 sites in Australia and New Zealand and look at how intravenous fluids are used to treat sepsis patients.

According to study leader Dr Stephen Macdonald, from the Harry Perkins Institute of Medical Research Centre for Clinical Research in Emergency Medicine and the Royal Perth Hospital Emergency Department, the ARISE is an important next step following the group's recent successful completion of an EMF-funded pilot clinical trial.

"The pilot trial ran across eight emergency departments in Western Australia, Victoria and Queensland and we compared two treatments at the opposing end of a spectrum of accepted practice for sepsis," said Dr Macdonald.

"We compared the outcomes from patients who were given the 'standard volume' treatment with a 'restricted volume' approach in which we gave patients less fluids and medications to increase their blood pressure," he said.

"The main purpose of the pilot was to determine if it was feasible to compare these two approaches, in particular if the restricted fluids treatment was safe for patients. Based on the results, which were recently published, we concluded that a restricted fluid approach was feasible and clinically acceptable.

"However, before we embark on a larger clinical trial we really need to understand current practice across a range of settings in both small and large hospitals, which is why we're doing this second ARISE Fluids study.

"Anecdotally, the incidence of sepsis has been rising over the past decade and we've been seeing a change in the spectrum of cases. Some types of infections have been reduced thanks to immunisations and others are increasing due to issues like antibiotic resistance."

Sepsis occurs when an infection hits the blood stream. It can affect everyone from babies to older adults, but in Australia people over 65 years are the largest single group to develop the illness.

EMF has also funded two other preclinical bodies of sepsis research (led by clinicians from The Prince Charles Hospital and the Royal Brisbane Hospital). The data from these studies will inform the design of a larger clinical trial following the completion of the ARISE Fluids study.

EMF's Queensland Research Program is fully funded by Queensland Health.
-end-


Emergency Medicine Foundation (Australia)

Related Blood Pressure Articles:

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.
Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.
The Lancet Neurology: High blood pressure and rising blood pressure between ages 36-53 are associated with smaller brain volume and white matter lesions in later years
A study of the world's oldest, continuously-studied birth cohort tracked blood pressure from early adulthood through to late life and explored its influence on brain pathologies detected using brain scanning in their early 70s.
Blood pressure control is beneficial, is it not?
Until recently, physicians had generally assumed that older adults benefit from keeping their blood pressure below 140/90 mmHg.
The 'blue' in blueberries can help lower blood pressure
A new study published in the Journal of Gerontology Series A has found that eating 200g of blueberries every day for a month can lead to an improvement in blood vessel function and a decrease in systolic blood pressure in healthy people.
How to classify high blood pressure in pregnancy?
The American Heart Association (AHA) and the American College of Cardiology (ACC) changed their guidance to lower the threshold criteria for hypertension in adults.
Discovery could advance blood pressure treatments
A team of Vanderbilt University Medical Center researchers, working with the US Department of Veteran's Affairs (VA), has discovered genetic associations with blood pressure that could guide future treatments for patients with hypertension.
Blue light can reduce blood pressure
Exposure to blue light decreases blood pressure, reducing the risk of developing cardiovascular disease, a new study from the University of Surrey and Heinrich Heine University Dusseldorf in collaboration with Philips reports.
Poor oral health linked to higher blood pressure, worse blood pressure control
Poor oral health may interfere with blood pressure control in people diagnosed with hypertension.
Largest ever genetic study of blood pressure
The largest ever genetic analysis of over one million people has identified 535 new genes associated with high blood pressure.
More Blood Pressure News and Blood Pressure Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.